Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic Stage IIIA (N2): Analysis of Cancer and Leukemia Group B Protocol 8935

Cancer

Volumn 77, Issue 11, 1996, Pages 2393-2399

  Kumar, Parvesh ^a,b   Herndon II, James ^c   Langer, Mark ^d,k   Kohman, Leslie J ^e   Elias, Anthony D ^f   Kass, Frederick C ^g   Eaton, Walter L ^h   Seagren, Stephen L ⁱ   Green, Mark R ⁱ   Sugarbaker, David J ^j  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Harvard Jt Ctr for Radiat Therapy   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g SANTA BARBARA COTTAGE HOSPITAL   (United States)

^h DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

more..

Author keywords

failure pattern; nonsmall cell lung carcinoma; Stage IIIA (N2); trimodality therapy

Indexed keywords

CISPLATIN; VINBLASTINE;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; THORACOTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; SURVIVAL RATE; THORACOTOMY; TREATMENT FAILURE; VINBLASTINE;

EID: 9344270526     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2393::AID-CNCR31>3.0.CO;2-Q     Document Type: Article

References (12)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. A Cancer J Clin 1996;46(1):5-28.
2. Dillman RO, Seagren SL, Propert K, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;320:940-5.
3. LeChevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83:417-23.
4. Weiden PL, Piantadosi S, for the Lung Cancer Study Group. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung carcinoma: a phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 1991;83:266-73.
5. Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994;330:153-8.
6. Strauss GM, Herndon JE, Sherman DD, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of the Cancer and Leukemia Group B Phase II Study. J Clin Oncol 1992;10:1237-44.
7. Burkes RL, Ginsberg RJ, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 1992;10:580-6.
8. 0 non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol 1989;40:266-74.
9. 2) non-small cell lung cancer. J Thorac Cardiovasc Surg. In press.
10. 2) non-small cell lung cancer (NSCLC) utilizing consolidative thoracic irradiation: results of Cancer and Leukemia Group B (CALGB) Trial 8935. Int J Radiat Oncol Biol Phys 1994;30(1):180.
11. Ohta O, Tsuchiya R, Shimoyama M, Sawamura K, Mori T, Miyazawa N, et al. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. J Thorac Cardiovasc Surg 1993;106:703-8.
12. Elias A, Skarin A, Gonin R, Oliynyk P, Stomper P, O'Hara C, et al. Neoadjuvant treatment of stage IIIA non-small-cell lung cancer. Am J Clin Oncol 1994;17(1):26-6.